The University of Birmingham and Acticor Biotech announce th

The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack

The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Mediolanum , Lombardia , Italy , United Kingdom , West Midlands , United Kingdom General , France , French , Mark Thomas , Jon Townend , Tim Mayo , Newton Biocapital , Adeline Meilhoc , University Of Birmingham , Cardiovascular Research Unit At Northern , University Hospitals Birmingham , Birmingham Health Partners , Venture Investment , Institute Of Cardiovascular Sciences , European Medicines Agency , Midlands Academic Health Science Network , French National Institute Of Health , University Of Sheffield , Consultant Cardiologist At University Hospitals Birmingham , Acticor Biotech News Releaselimited , Acticor Biotech , First Patient , Queen Elizabeth Hospital , Northern General Hospital , Associate Professor , Honorary Consultant Cardiologist , Robert Storey , Cardiovascular Research Unit , Consultant Cardiologist , Honorary Professor , Cardiovascular Sciences , Chief Investigator , Global Clinical Development , Press Office , Health Partners , West Birmingham Hospitals , French National Institute , Medical Research , Lancet Neurology , Euronext Growth Paris , Media Relations ,